FDA Recall of Potassium Chloride Capsules
FDA announces recall of potassium chloride capsules due to failed dissolution, which could lead to heart attacks. Two brands are affected, Glenmark Pharmaceuticals and American Health Packaging.
Key Points
- Potassium chloride capsules are being recalled due to failed dissolution
- Consumers' potassium levels could elevate, leading to heart attacks
- The capsules are intended for patients with low potassium levels
- No reported hyperkalemia cases or serious adverse events yet